Saturday, November 23, 2024
HomeTagsFirst Participant Dosed

First Participant Dosed

Santhera and ReveraGen Announce First Participant Dosed in FDA-funded Phase 2 Pilot Study

Santhera Pharmaceuticals and ReveraGen BioPharma, Inc announce that the first patient has been dosed in a Phase 2 pilot study to assess vamorolone in...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics